EUVIMEDEUVIMED entdecken
Klinische Studie

Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study

Zoe Diana Draelos, Mahmoud Ghannoum, Linda Stein Gold, Julie C Harper, Hilary Baldwin, Eric Guenin, Emil A Tanghetti

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.9018 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Zoe Diana Draelos und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acne Vulgaris, Clindamycin, Dermatologic Agents, Benzoyl Peroxide. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisClindamycinDermatologic AgentsBenzoyl PeroxideAdapalene, Benzoyl Peroxide Drug CombinationHumansFemaleMaleAdolescentTreatment OutcomeAdultYoung AdultDrug CombinationsChildSeverity of Illness IndexAnti-Bacterial Agents

Substanzen

ClindamycinDermatologic AgentsDrug CombinationsBenzoyl PeroxideAdapalene, Benzoyl Peroxide Drug Combinationclindamycin phosphateAnti-Bacterial Agents

Zitieren

APA

Draelos, Z. D., Ghannoum, M., Stein Gold, L., Harper, J. C., Baldwin, H., Guenin, E., & Tanghetti, E. A. (2025). Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9018

Vancouver

Draelos ZD, Ghannoum M, Stein Gold L, Harper JC, Baldwin H, Guenin E, et al. Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9018

BibTeX
@article{Draelos2025,
  author = {Draelos, Zoe Diana and Ghannoum, Mahmoud and Stein Gold, Linda and Harper, Julie C and Baldwin, Hilary and Guenin, Eric and Tanghetti, Emil A},
  title = {Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.9018}
}
Kostenlos starten →